NCT04926948View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

May 25, 2026

Study Completion Date

May 25, 2026

Conditions

Pleural Mesothelial Neoplasm

Interventions

OTHER

Immunotherapy

Immunotherapy

OTHER

Quality-of-Life Assessment

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04926948 - Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma | Biotech Hunter | Biotech Hunter